`
`
`EXHIBIT A
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 1 of 10
`
`
`
`EXHIBIT A
`
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 2 of 10
`
`IN THE SUPERIOR COURT OF MURRAY COUNTY
`STATE OF GEORGIA
`
`CLERK OF SUPERIOR COURT
`MURRAY COUNTY, GEORGIA
`
`22-CI-0144
`JIM WILBANKS
`MAR 16, 2022 11:03 AM
`
`
`STEPHEN SWINNEY, Individually and :
`in his capacities as Administrator of :
`the estate of Megan Swinney and as :
`next friend of minor child, H.S.
`:
`
`
`
`
`
`
`:
`
`
`Plaintiff,
`
`
`:
`
`
`
`
`
`
`:
`vs.
`
`
`
`
`
`:
`
`
`
`
`
`
`:
`MYLAN PHARMACEUTICALS, INC.;
`:
`VIATRIS SPECIALTY, LLC; and
`:
`VIATRIS, INC.
`
`
`
`:
`
`
`
`
`
`
`:
`
`
`Defendants.
`
`:
`
`
`
`
`
`CIVIL ACTION NO._______________
`
`COMPLAINT FOR DAMAGES
`
`COMES NOW Plaintiff, Stephen Swinney, in his capacities as Administrator of the
`
`estate of Megan Swinney and as next friend of minor child, H.S., by and through counsel,
`
`and files this Complaint for Damages and in support thereof show the Court the following:
`
`PARTIES AND JURISDICTION
`
`-1-
`
`
`
`Stephen Swinney is the surviving spouse of the late Megan Swinney, and he is
`
`domiciled in Murray County, Georgia. Stephen Swinney is also the duly appointed
`
`Administrator of the estate of Megan Swinney, which is an open estate before the
`
`Probate Court of Murray County, Georgia.
`
`-2-
`
`
`
`H.S. is the sole surviving child of the late Megan Swinney. H.S. is domiciled in
`
`Murray County, Georgia where she resides with her natural father, Stephen Swinney.
`
`
`
`EXHIBIT A
`
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 3 of 10
`
`-3-
`
`
`
`Defendant Mylan Pharmaceuticals, Inc. (“Mylan” hereafter) is a West Virginia
`
`corporation, authorized to and conducting business within the state of Georgia.
`
`Defendant is subject to the jurisdiction of this Court pursuant to the Georgia long-arm
`
`statute, codified O.C.G.A. 9-10-91, by virtue of conducting business within the state of
`
`Georgia and having committed one or more torts within the state of Georgia. Venue is
`
`proper in this Court pursuant to O.C.G.A. 14-2-510(B)(4) by virtue of the events giving
`
`rise to this cause of action sounding in tort having occurred within Murray County,
`
`Georgia. This defendant may be served via its Georgia registered agent, CT Corporation
`
`System, at 289 S. Culver Street, Lawrenceville, GA 30046.
`
`-4-
`
`
`
`Defendant Viatris Specialty, LLC is a company formed under the laws of the state
`
`of Delaware with its principal office located in Pennsylvania, authorized to and
`
`conducting business within the state of Georgia. Defendant is subject to the jurisdiction
`
`of this Court pursuant to the Georgia long-arm statute, codified O.C.G.A. 9-10-91, by
`
`virtue of conducting business within the state of Georgia and having committed one or
`
`more torts within the state of Georgia. Venue is proper in this Court pursuant to
`
`O.C.G.A. 14-2-510(B)(4) by virtue of the events giving rise to this cause of action
`
`sounding in tort having occurred within Murray County, Georgia. This defendant may
`
`be served via its Georgia registered agent, CT Corporation System, at 289 S. Culver
`
`Street, Lawrenceville, GA 30046.
`
`
`
`
`
`
`
`2
`
`EXHIBIT A
`
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 4 of 10
`
`-5-
`
`
`
`Defendant Viatris, Inc. is a corporation formed under the laws of the state of
`
`Delaware with its principal office located in Pennsylvania conducting business within the
`
`state of Georgia. Defendant is subject to the jurisdiction of this Court pursuant to the
`
`Georgia long-arm statute, codified O.C.G.A. 9-10-91, by virtue of conducting business
`
`within the state of Georgia and having committed one or more torts within the state of
`
`Georgia. Venue is proper in this Court pursuant to O.C.G.A. 14-2-510(B)(4) by virtue of
`
`the events giving rise to this cause of action sounding in tort having occurred within
`
`Murray County, Georgia. This defendant may be served via its Pennsylvania registered
`
`agent, Brian Roman, at 1000 Mylan Boulevard, Canonsburg, PA, 15317.
`
`FACTUAL ALLEGATIONS COMMON TO ALL COUNTS
`
`-6-
`
`
`
`On or about April 4, 2020 Megan Swinney suddenly lost consciousness at her
`
`home where she died in front of her husband and young child, H.S. as her husband
`
`attempted CPR until paramedics arrived.
`
`-7-
`
`
`
`Upon conducting an autopsy of her body, it was discovered that Megan
`
`Swinney’s cause of death was acute Pulmonary Thromboembolism in her lungs
`
`resulting from Deep Vein Thrombosis (“DVT”) or blood clot in layman’s terms.
`
`-8-
`
`
`
`At the time of her death and the preceding months, Megan Swinney was using
`
`the prescription birth control patch, Xulane, which is a norelgestromin and ethinyl
`
`estradiol transdermal medication. Xulane was previously a generic label, and the brand
`
`
`
`3
`
`EXHIBIT A
`
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 5 of 10
`
`label was called Ortho Evra. By the time Megan Swinney was using this medication,
`
`the manufacturer of Ortho Evra had ceased the sale of Ortho Evra within the United
`
`States and had forfeited its brand label status and accompanying FDA obligations to
`
`Defendants as the sole manufacturer and distributor of this medication within the United
`
`States.
`
`-9-
`
`
`
`Xulane was manufactured and marketed by Defendant Mylan at the time it was
`
`proscribed to and used by Ms. Swinney.
`
`-10-
`
`
`
`Upon information and belief, Mylan has subsequently merged or otherwise
`
`changed its corporate identity to now be known as Viatris, Inc. and/or Viatris Specialty,
`
`LLC. Upon information and belief, resulting from a merger and/or asset purchase
`
`agreement, Viatris, Inc. and Viatris Specialty, LLC are jointly and severally liable in the
`
`same manner as Mylan for all liability as alleged in this suit.
`
`-11-
`
`
`
`Unknown to Ms. Swinney or her physicians but known to Defendants prior to Ms.
`
`Swinney’s death, Xulane posed an extreme risk of causing DVT among women with a
`
`body mass index (BMI) of 30 kg/m2 or more.
`
`-12-
`
`
`
`Ms. Swinney’s body mass index was greater than 30 kg/m2 at all times during
`
`which she was using the Xulane patch, and use of the Xulane patch directly and
`
`proximately caused her death.
`
`
`
`
`
`4
`
`EXHIBIT A
`
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 6 of 10
`
`-13-
`
`
`
`The product label for Xulane at all times prior to Megan Swinney’s death contained
`
`no warning that the product was dangerous for women with a BMI of 30 kg/m2 or more.
`
`COUNT I – STRICT LIABILITY FOR PRODUCT MANUFACTURERS
`
`-14-
`
`
`
`At the time Defendants sold the Xulane patches to Ms. Swinney, the patches were
`
`not merchantable and reasonably suited to the use intended, i.e. safely preventing
`
`pregnancy in a woman with a body mass equal to or greater than 30 kg/m2. The
`
`packaging was also defective for failing to warn against this known defect as discussed
`
`more particularly in Count II herein.
`
`-15-
`
`
`
`The unsuitability and defective nature of the Xulane patches directly and
`
`proximately caused Ms. Swinney’s death, pain and suffering, and emotion anguish for her
`
`family.
`
`-16-
`
`
`
`Defendants are strictly liable for these damages as well as the medical expenses
`
`incurred in relation to attempts to save Ms. Swinney’s life pursuant to O.C.G.A. §51-1-11.
`
`COUNT II – FAILURE TO WARN
`
`-17-
`
`
`
`Prior to Ms. Swinney’s death, Defendants knew or should have known that Xulane
`
`posed a serious risk of DVT and death to women whose body mass is 30 kg/m2 or greater.
`
`
`
`
`
`
`
`5
`
`EXHIBIT A
`
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 7 of 10
`
`-18-
`
`
`
`Defendants had a duty to warn Ms. Swinney and others of the known danger
`
`pursuant to O.C.G.A. §51-1-11 and pursuant Georgia’s common-law negligence
`
`obligation to exercise reasonable care.
`
`-19-
`
`
`
`Defendants’ breach of their duty to warn of the known danger directly and
`
`proximately caused Ms. Swinney’s death, pain and suffering, and emotion anguish for her
`
`family.
`
`-20-
`
`
`
`Defendants are strictly liable for these damages as well as the medical expenses
`
`incurred in relation to attempts to save Ms. Swinney’s life.
`
`COUNT III – FAILURE TO TIMELY REPORT ADVERSE DRUG EXPERIENCES
`
`-21-
`
`
`
`At all times after Defendants obtained the brand-label status for Xulane, they had
`
`a duty to timely report adverse drug experiences to the Food and Drug Administration
`
`(“FDA”) pursuant to 21 C.F.R. §310.305 and other statutes or regulations.
`
`
`
`Upon information and belief Defendants received notice of adverse drug
`
`-22-
`
`experiences and failed to timely report them to the FDA.
`
`-23-
`
`
`
`The FDA’s reporting obligations were designed to protect consumers, and Ms.
`
`Swinney was a member of the class intended to be protected.
`
`
`
`
`
`6
`
`EXHIBIT A
`
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 8 of 10
`
`
`
`The type of harm Ms. Swinney suffered was the type of harm that the reporting
`
`-24-
`
`obligations were designed to prevent.
`
`-25-
`
`
`
`Defendants’ failure to timely report adverse drug experiences amounts to
`
`negligence per se and directly and proximately caused Ms. Swinney’s death, pain and
`
`suffering, and emotion anguish for her family.
`
`-26-
`
`
`
`Defendants were negligent per se and are liable for these damages as well as the
`
`medical expenses incurred in relation to attempts to save Ms. Swinney’s life.
`
`COUNT IV – NEGLIGENT RESEARCH AND TESTING
`
`-27-
`
`
`
`The reason the manufacturer of Ortho Evra ceased sale of the product within the
`
`United State was because the product was causing an unacceptable rate of bloods clots
`
`and death among its users.
`
`-28-
`
`
`
`
`
`Defendants knew or should have known this to be the case.
`
`-29-
`
`Following the removal of Ortho Evra from the market, Defendants had a duty to
`
`exercise reasonable care in conducting further testing and research to determine the
`
`circumstance in which Xulane could be safely used for contraceptive purposes.
`
`
`
`
`
`
`
`7
`
`EXHIBIT A
`
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 9 of 10
`
`
`
`Defendants either failed to conduct research and testing at all or they failed to
`
`-30-
`
`conduct adequate testing and research in breach of their duty.
`
`-31-
`
`
`
`Defendants’ breach of this duty directly and proximately caused Ms. Swinney’s
`
`death, pain and suffering, and emotion anguish for her family.
`
`-32-
`
`
`
`Defendants are liable for these damages as well as the medical expenses incurred
`
`in relation to attempts to save Ms. Swinney’s life.
`
`COUNT V – WRONGFUL DEATH
`
`-33-
`
`
`
`Defendants failures as alleged in this Complaint directly and proximately caused
`
`the homicide of Megan Swinney.
`
`-34-
`
`
`
`Pursuant to O..C.G.A. §51-4-2, Defendants are liable to Plaintiff for the full value
`
`of Ms. Swinney’s life.
`
`COUNT VI - PUNITIVE DAMAGES
`
`-35-
`
`
`
`Defendant’s failures as alleged herein exhibited willful and wanton behavior with a
`
`complete disregard and conscious indifference for the safety of others such that an award
`
`punitive and exemplary damages are appropriate pursuant to O.C.G.A. §51-12-5.1.
`
`Plaintiff is also entitled to an award of attorney’s fees and expenses due to the nature of
`
`Defendants’ conduct.
`
`
`
`8
`
`EXHIBIT A
`
`
`
`Case 4:22-cv-00090-MLB Document 1-1 Filed 04/15/22 Page 10 of 10
`
`
`
`WHEREFORE, Plaintiff prays as follows:
`
`1.
`
`That Defendants be served with process and required to answer these
`
`allegations within the time permitted by law;
`
`2.
`
`That Plaintiff be awarded damages for the full value of the life of Megan Swinney
`
`in addition to her medical expenses, her pain and suffering, and the family’s
`
`mental anguish in an amount to be proven at trial;
`
`3.
`
`That Defendant be ordered to pay punitive damages as well as all of Plaintiff’s
`
`attorney’s fees and expenses;
`
`4.
`
`That Plaintiff be awarded all pre-judgment and post-judgment interest allowed by
`
`law;
`
`5.
`
`That Plaintiff be awarded any other relief the court determines equitable and
`
`proper; and
`
`6.
`
`That a jury of twelve be empaneled to determine all issues of fact in this action,
`
`for which demand is hereby made.
`
`Respectfully submitted this 16th day of March, 2022.
`
`
`MCCAMY, PHILLIPS, TUGGLE & FORDHAM LLP
`
`
`
`
`
`BY:
`
`
`
` /s/ Nathan D. Lock
`SAMUEL L. SANDERS
`Georgia Bar No. 140865
`ssanders@mccamylaw.com
`NATHAN D. LOCK
`Georgia Bar No. 948780
`nlock@mccamylaw.com
`P. O. Box 1105
`Dalton, GA 30722-1105
`P:706-278-4499
`F:706-529-8814
`Attorneys for Plaintiff
`
`9
`
`
`
`
`
`
`
`
`EXHIBIT A
`
`